Vaia Lambadiari

16PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersMedical roboticsGene and molecular therapyImmunogenetics (incl. genetic immunology)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 02, 2026
Myocardial deformation links combined liraglutide-empagliflozin therapy with improved cardiovascular and economic outcomes in type 2 diabetes: a 6-year study.

|Feb 17, 2026
780G Hybrid Closed-Loop Pump as Adjunct to Metreleptin in Lipodystrophy-Associated Diabetes: Three Case Observations.

Emmanouil Korakas, Aikaterini Kountouri, Loukia Pliouta

|Oct 13, 2025
Metreleptin In SHORT Syndrome With Uncontrolled Diabetes.

Emmanouil Korakas, Aikaterini Kountouri, Ignatios Ikonomidis

|Feb 25, 2025
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance.

Maria Apostolopoulou, Vaia Lambadiari, Michael Roden

|Dec 23, 2024
Response to "Letter to Editor From Ishaq MU et al: 'Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease'".

Emmanouil Korakas, Aikaterini Kountouri, George Pavlidis

|Jul 24, 2024
Differential effects of heat-not-burn, electronic, and conventional cigarettes on endothelial glycocalyx.

Ignatios Ikonomidis, Konstantinos Katogiannis, Kallirhoe Kourea

Pageof 3

Frequent Collaborators

7 joint publications

Ignatios Ikonomidis

5 joint publications

Konstantinos Katogiannis

3 joint publications

Emmanouil Korakas

3 joint publications

Aikaterini Kountouri